To determine whether TRAIL–CDK9i may be effective at killing cancer cells in a clinically relevant experimental model of PDAC, we made use of organoid cultures which closely resemble the three-dimensional in vivo structure of PDAC tumors [40]. The gene discussed is TNFSF10; the disease is cancer.